United States: Class Action Defendants Win Home Court Advantage In Supreme Court Ruling On Specific Jurisdiction In Bristol-Myers Case

In a decisive 8-1 vote, the U.S. Supreme Court rejected a theory of specific jurisdiction that would allow a state court to assert specific jurisdiction over the claims of out-of-state plaintiffs whose claims were not directly linked with that state. The opinion in the case, Bristol-Myers Squibb Co. v. Superior Court of California, authored by Justice Samuel A. Alito Jr., came down on June 19. Justice Alito explained that neither the similarity of claims between in-state and out-of-state plaintiffs, nor the defendant's contacts with a state can provide a basis for specific jurisdiction. Rather, the Court reaffirmed that "specific jurisdiction is confined to adjudication of issues deriving from, or connected with, the very controversy that establishes jurisdiction."

Jurisdictional Developments

A state court's jurisdiction extends to all controversies in which it may issue a binding judgment on the defendant. Over the years, the Court has defined two forms of jurisdiction a state may assert—general and specific. General jurisdiction is typically proper if the defendant is closely connected with the state. Specific jurisdiction is proper if the claims are related to the defendant's conduct within that state.

In recent years, the Court has clarified both of these standards to limit state jurisdictional authority. In both the Goodyear Dunlop Tires Operations v. Brown and Daimler AG v. Bauman cases, the Court limited a state's assertion of general jurisdiction to defendants that are either incorporated or have their principal place of business within that state. Then, in Walden v. Fiore, the Court tightened the standard for a state's assertion of specific jurisdiction, clarifying that a defendant's contacts with a state-resident plaintiff cannot serve as the sole connection between that state and that defendant.

Background on the Decision

In 2013, 659 plaintiffs brought claims against Bristol-Myers Squibb Company, alleging that they suffered harm by using Plavix—a drug manufactured and sold by BMS. The plaintiffs—which included 575 non-Californians—brought these claims in California Superior Court. BMS challenged the Superior Court's jurisdiction to adjudicate the claims of the non-residents. The Superior Court ruled that it could assert both general and specific jurisdiction over BMS, and BMS appealed.

The California Appellate Court initially affirmed the Superior Court, but later reversed its general jurisdiction determination in light of the Supreme Court's decision in Daimler. BMS appealed the Appellate Court's affirmance of the specific jurisdiction determination to the California Supreme Court. The California Supreme Court affirmed, explaining that specific jurisdiction over non-resident claims against BMS was proper because "BMS's forum contacts, including its California-based research and development facilities, are substantially connected to the nonresident plaintiffs' claims because those contacts are part of the nationwide marketing and distribution of Plavix, a drug BMS researched and developed, that gave rise to all the plaintiffs' claims."

The Supreme Court's Decision

In a much anticipated decision, the Supreme Court reversed the California Supreme Court, reaffirming the principle that specific jurisdiction can only be asserted when there is a direct connection between the asserted claims and the defendant's conduct within the forum state. In straightforward prose, the Court explained that "[w]hat is needed [for specific jurisdiction to be proper]—and what is missing here—is a connection between the forum and the specific claims at issue." The Court rejected the California Supreme Court's evaluation of the defendant's general contacts with the state for the purposes of finding specific jurisdiction. Justice Alito directly rebuffed this approach as "difficult to square with our precedents" and "resembl[ing] a loose and spurious form of general jurisdiction." Further, the Court was unpersuaded that the effect on mass action claims merited a different outcome. Justice Alito explained that the "decision does not prevent the California and out-of-state plaintiffs from joining together in a consolidated action in the States that have general jurisdiction over BMS." Interestingly, the Court concluded with an explicit statement that its ruling did not address "whether the Fifth Amendment imposes the same restrictions on the exercise of personal jurisdiction by a federal court."

In lone dissent, Justice Sonia Sotomayor criticized the Court's opinion as insulating nationwide corporations from consolidated mass actions, and forcing piecemeal litigation.

The Takeaways

On the whole, the Bristol Myers-Squibb decision is more significant for what it rejected than for what it held. The California Supreme Court's decision was viewed by many as a sideways challenge to the Court's recent restriction of general jurisdiction, which limited its exercise to a defendant's home court. The California Supreme Court's analysis opened the door to exercising specific jurisdiction over defendants with strong ties to a forum. In this opinion, the Supreme Court unequivocally shut that door, consolidating its recent shifts on personal jurisdiction.

Justice Sotomayor's dissent, in addition to concluding that specific jurisdiction was proper in this case, dropped a footnote addressing California's capacity to exercise general jurisdiction (an issue not before the Court) and expressing skepticism of the Court's post-Daimler analysis, writ large. However, given the 8-1 vote, Justice Sotomayor's favored approach seems destined for dissent in the foreseeable future.

The majority opinion and the dissent did agree on at least one thing: going forward, there is no question that state court mass actions with nationwide plaintiffs are limited to a forum that can exercise general jurisdiction—i.e. a defendant's home state. This fact may limit a defendant's exposure to certain state law causes of action, and will certainly reduce the instances in which a defendant is forced to litigate in an unfamiliar forum.

One remaining question for defendants and plaintiffs alike is whether the jurisdiction of federal courts is equally limited under the Fifth Amendment. Although largely settled in the minds of most practitioners and judges, the Supreme Court has never formally held that federal district courts cannot exercise personal jurisdiction based on a defendant's nationwide contacts. With the majority's express reservation of this question—and its portentous citation to a thirty year-old case reserving the same question—there is reason to think that the Supreme Court will continue to modify the standards for determining personal jurisdiction going forward.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Events from this Firm
2 Oct 2018, Webinar, California, United States

This CLE webinar will offer suggestions to litigators to help them comply with the new GDPR during e-discovery.

10 Oct 2018, Webinar, California, United States

For the past years, 3D printing has significantly revolutionized the business industry as it provides innovations and improvement to pre-existing processes.

16 Oct 2018, Other, California, United States

This highly interactive colloquium will provide a deep understanding and practical advice regarding major e-discovery challenges facing organizations t​oday.

Similar Articles
Relevancy Powered by MondaqAI
In association with
Related Topics
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions